SLRN
ACELYRIN, INC. Common Stock
NASDAQ: SLRN · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.00% today
Updated 2026-04-30
Market cap
$229.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.69
Dividend yield
—
52W range
$2 – $3
Volume
4.1M
ACELYRIN, INC. Common Stock (SLRN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+8.3%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-52.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-11.4%
2025-05-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-05-12 | $-0.55 | +42.1% | $2.36 | $2.09 | -11.4% |
| 2025-03-27 | $-0.79 | -17.9% | $2.54 | $2.60 | +2.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-03-31 | $-0.95 | $-0.55 | +42.1% | — | — |
| 2024-12-31 | $-0.67 | $-0.79 | -17.9% | — | — |
| 2024-09-30 | $-0.80 | $-0.49 | +38.8% | — | — |
| 2024-06-30 | $-0.66 | $-0.86 | -29.7% | — | — |
| 2024-03-31 | $-0.98 | $-0.36 | +63.3% | — | — |
| 2023-12-31 | $-0.99 | $-0.97 | +2.0% | $166000.00 | — |
| 2023-09-30 | $-0.50 | $-0.87 | -74.0% | — | — |
| 2023-06-30 | $-0.76 | $-0.40 | +47.4% | — | — |
| 2023-03-31 | $-10.89 | $-2.11 | +80.6% | — | — |
Frequently asked questions
Has ACELYRIN, INC. Common Stock beaten earnings estimates?
ACELYRIN, INC. Common Stock has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +8.3% over the last 4 quarters.
How does SLRN stock react to earnings?
SLRN stock has moved an average of -4.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.